YOLFTbeta
Volitionrx Ltd

Volitionrx Ltd

VNRX · AMEX · Healthcare / Medical Devices

0.23USD+0.05 (+24.66%)

Price History

Full chart

Market Stats

Previous Close0.1845
Open0.1997
Day Range0.1935 – 0.242
52-Week Range0.2306 – 13.58
Volume56.94M
Market Cap7.60M
P/E (TTM)0.00
Forward P/E20.83
EPS-3.85
Dividend Yield0.00%
Beta1.09
50-Day Avg0.5438
200-Day Avg2.81

About

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Cameron Reynolds MBA
  • Employees57
  • Headquarters1489 West Warm Springs Road, Henderson, NV, United States, 89014, USA
  • Websitehttps://volition.com

Leadership

  • Mr. Cameron Reynolds MBAFounder, CEO, President & Director · b. 1971
  • Dr. Gaetan Michel Ph.D.Chief Operating Officer · b. 1973
  • Mr. Terig HughesCFO & Treasurer · b. 1970
  • Dr. Jacob Vincent Micallef MBA, Ph.D.Chief Scientific Officer · b. 1956
  • Mr. Nicholas PlummerGroup General Counsel · b. 1971
  • Ms. Louise Batchelor DayGroup Chief Marketing & Communications Officer · b. 1971
  • Dr. Jasmine Kway Ph.D.Chief Revenue Officer · b. 1972
  • Mr. Gael Forterre M.B.A.Chief Licensing Officer · b. 1981
  • Mr. Rodney Gerard Rootsaert LLBCorporate Secretary · b. 1971

Financials

Income Statement

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--------54.97K014.79K000017.10K13.43K90.03K306.39K775.30K1.23M1.73M
Growth (%)----------100.00%--100.00%-----21.43%+570.25%+240.30%+153.04%+59.10%+40.04%
Cost of Revenue---4.00K----4.00M05.81M0309.41K542.48K639.92K---1.19M1.41M1.30M-
Gross Profit----4.00K----54.97K014.79K0-309.41K-542.48K-639.92K17.10K13.43K90.03K306.39K775.30K1.23M1.73M
Gross Margin--------100.00%-100.00%----100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Expense---22.30K----4.14M4.58M5.95M10.01M11.96M14.50M17.26M16.06M21.26M28.42M32.09M36.76M28.26M22.95M
Operating Income-24.18K-24.18K-36.99K-26.30K-21.80K-15.82K-10.95K-2.61M-4.08M-4.58M-5.94M-10.01M-12.27M-15.05M-17.90M-16.04M-21.25M-28.33M-31.78M-35.99M-27.02M-21.22M
Operating Margin---------7428.05%--40158.37%-----93840.22%-158176.25%-31468.96%-10372.36%-4641.76%-2190.90%-1228.57%
EBITDA--13.11K-36.99K-26.30K-21.80K-15.82K-10.95K-13.02K-3.95M-3.56M-8.07M-9.96M-11.60M-14.15M-17.26M-15.07M-19.23M-25.69M-29.24M-34.04M-25.58M-19.80M
EBITDA Margin---------7181.10%--54591.78%-----88149.69%-143140.94%-28532.04%-9541.84%-4390.83%-2073.65%-1146.10%
Net Income-24.18K-24.18K-36.99K-26.30K-21.80K-15.82K-10.95K-2.61M-4.08M-3.71M-8.21M-9.53M-11.91M-14.77M-18.01M-16.10M-20.35M-26.81M-30.27M-35.32M-26.97M-23.36M
Net Income Margin---------7428.05%--55553.12%-----94168.55%-151508.34%-29782.49%-9879.11%-4555.53%-2186.27%-1352.16%
R&D-------1.51M2.84M2.50M4.04M6.10M6.84M8.91M10.91M10.36M14.53M13.02M15.33M19.55M14.41M10.08M
R&D as % of Total Revenue--------5171.34%-27352.20%----60618.00%108195.21%14463.72%5004.37%2521.79%1167.93%583.62%
Interest Expense00000000000663.80K073.13K110.92K126.57K129.80K155.80K173.09K221.62K340.36K2.49M
Interest Expense % of Total Revenue--------0.00%-0.00%----740.36%966.27%173.05%56.49%28.59%27.59%144.11%

Balance Sheet

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets681032.26K4.34K3.32K3.44K4852.25M2.22M2.07M3.43M7.71M24.73M14.62M17.49M21.29M26.15M27.49M18.30M27.95M9.40M6.90M
Total Liabilities64.10K73.04K58.48K82.66K99.24K110.98K114.77K1.16M1.38M1.39M3.06M1.67M3.56M4.67M5.35M7.09M9.86M9.77M21.42M36.66M35.51M42.49M
Total Equity-64.03K-72.94K-56.23K-78.32K-95.92K-107.54K-114.29K1.09M833.79K680.67K368.18K6.04M21.18M9.96M12.14M14.20M16.34M17.94M-2.57M-7.80M-24.91M-34.25M
Cash681032.26K4.34K3.32K3.44K485347.89K376.42K888.70K2.14M5.92M21.68M10.12M13.43M16.97M19.44M20.58M10.87M20.73M3.26M1.12M
Total Debt-------620.00K52.86K430.00K351.77K629.21K1.67M2.96M3.58M4.10M4.44M4.02M4.97M5.86M5.82M11.46M
Net Debt-68-103-2.26K-4.34K-3.32K-3.44K-485-347.89K-323.56K-888.70K-2.14M-5.53M-20.21M-7.35M-10.16M-13.03M-15.00M-16.56M-5.89M-14.87M2.56M10.35M

Cash Flow

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6335-50.00K-17.31K39.95K-5.75K-4.65K-1.69M-2.31M-3.08M-4.14M-8.77M-9.06M-12.19M-14.73M-12.74M-16.46M-20.85M-15.28M-18.06M-25.89M-19.68M
Investing Cash Flow-----40.97K---34.87K-90.69K-714-302.99K-352.24K-415.09K-1.43M-301.81K-511.27K-1.65M-973.56K-1.57M-1.08M-573.85K-89.56K
Financing Cash Flow--52.15K19.39K-5.87K1.69K2.02M2.47M3.59M5.74M12.88M25.38M1.97M17.97M16.93M20.62M22.86M6.94M28.98M8.66M17.09M
Capital Expenditure000000034.87K90.69K714302.99K352.24K415.09K1.43M301.81K511.27K1.94M973.56K1.57M1.08M573.85K89.56K
Free Cash Flow-6335-50.00K-17.31K39.95K-5.75K-4.65K-1.72M-2.41M-3.08M-4.44M-9.12M-9.47M-13.62M-15.03M-13.25M-18.41M-21.83M-16.85M-19.15M-26.47M-19.77M
Dividends Paid----------------346.46K130.43K180.47K1.65M--
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%102.07%103.92%100.02%107.32%104.02%104.58%111.69%102.05%104.01%111.79%104.67%110.28%106.00%102.22%100.45%
Dividend Paid to FCF-----------------1.88%-0.60%-1.07%-8.64%--

Earnings

Report DateNov 30, 2009Feb 28, 2010May 31, 2010Aug 31, 2010Nov 30, 2010Feb 28, 2011May 31, 2011Aug 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Oct 31, 2013Mar 28, 2014Mar 31, 2014Aug 1, 2014Nov 6, 2014Mar 18, 2015May 12, 2015Aug 11, 2015Nov 4, 2015Mar 11, 2016May 13, 2016Aug 11, 2016Nov 10, 2016Mar 10, 2017May 11, 2017Aug 9, 2017Nov 9, 2017Mar 1, 2018May 10, 2018Aug 13, 2018Nov 7, 2018Mar 13, 2019May 8, 2019Aug 12, 2019Nov 12, 2019Feb 20, 2020May 7, 2020Aug 13, 2020Nov 12, 2020Mar 22, 2021May 11, 2021Aug 11, 2021Nov 10, 2021Mar 30, 2022May 11, 2022Aug 10, 2022Nov 14, 2022Mar 15, 2023May 10, 2023Aug 14, 2023Nov 14, 2023Mar 25, 2024May 13, 2024Aug 14, 2024Nov 14, 2024Mar 31, 2025May 15, 2025Aug 14, 2025Nov 13, 2025Mar 31, 2026May 14, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate---------------1.80-1.80--1.80-1.80-2.00-0.12-2.67-2.60-0.16-2.80-2.45-2.65-0.13-2.75-2.80-3.00-0.16-3.20-3.00-2.80-0.13-2.40-2.27-2.10-2.20-1.93-2.45-2.20-0.10-2.27-2.33-2.07-0.140.90-2.87-2.93-0.15-2.70-2.87-2.47-0.11-2.15-1.85-1.30-1.07-0.06-1.00-1.04-0.05-0.73-0.68-0.48
EPS Actual-0.03-0.03-0.03-0.01-0.04-0.02-0.02-0.03-1.85-2.06-1.80-3.16-1.78-1.97-1.60-1.40-3.58-1.56-2.61-2.00-0.12-2.00-3.20-0.15-2.60-2.60-3.00-0.12-2.60-2.60-3.00-0.15-3.40-3.00-2.80-0.11-2.40-2.20-2.00-1.60-2.80-2.36-1.93-0.11-2.40-2.08-2.60-0.15-2.80-2.80-2.80-0.13-3.00-2.80-2.14-0.11-2.00-1.60-1.40-1.20-0.06-1.31-1.06-0.05-0.97-0.78-
Surprise--------------11.11%22.22%-13.33%-45.00%0.00%0.00%25.09%-23.08%6.25%7.14%-6.12%-13.21%7.69%5.45%7.14%0.00%6.25%-6.25%0.00%0.00%15.38%0.00%3.08%4.76%27.27%-45.08%3.67%12.27%-10.00%-5.73%10.73%-25.60%-7.14%-411.11%2.44%4.44%13.33%-11.11%2.44%13.36%0.00%6.98%13.51%-7.69%-12.15%0.00%-31.00%-1.92%2.78%-32.88%-14.71%-
Timing--------------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap7.60M
Enterprise Value15.51M
Trailing P/E0.00
Forward P/E20.83
PEG Ratio0.00
Price / Sales3.09
Price / Book38.44
EPS-3.85
Book Value-2.67
Revenue (TTM)2.46M
Gross Profit (TTM)2.46M
EBITDA-18.57M
Profit Margin0.00%
Operating Margin-1042.50%
Return on Equity-730.06%
Return on Assets-142.94%
Shares Outstanding30.06M
Shares Float12.06M
Beta1.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 6 analystsTarget 13.62
  • Strong Buy
    3
  • Buy
    2
  • Hold
    1

Stock Splits

  • Apr 28, 20261:20